The findings from the GEO and TCGA datasets indicate that IGF2 methylation in tissues can discern colorectal adenomas or CRCs from normal intestinal mucosa, which also suggests that IGF2 methylation may prove valuable during CRC screening for early cancer detection. This evidence concerns the gene IGF2 and cancer.